References
- Stokes JR, Casale TB. Characterization of asthma endotypes: implications for therapy. Ann Allergy Asthma Immunol. 2016;117:121–125.
- Desai M, Oppenheimer J. Elucidating asthma phenotypes and endotypes: progress towards personalized medicine. Ann Allergy Asthma Immunol. 2016;116:394–401.
- Hinks TS, Zhou X, Staples KJ, et al. Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms. J Allergy Clin Immunol. 136:323–333.
- Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377:965–976.
- Aron JL, Akbari O. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma. Allergy. 2017;72:1148–1155.
- Low TL, Thurman GB, Chincarini C, et al. Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. 1979. Ann N Y Acad Sci. 2012 Oct;1269:131–146.
- Marshall GD Jr, Thurman GB, Rossio JL, et al. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice. J Immunol. 1981;126:741–744.
- King R, Tuthill C. Immune modulation with thymosin alpha 1 treatment. Vitam Horm. 2016;102:151–178.
- Hannappel E. beta-Thymosins. Ann N Y Acad Sci. 2007;1112:21–37.